Anthropic’s Claude Prices Fall as Compute Costs Outpace Sales Ahead of IPO

The squeeze here is structural, not cyclical: falling Claude prices signal inference is commoditizing fast, while compute costs outrunning sales shows Anthropic hasn't yet converted scale into operating leverage. That combination is what IPO investors will scrutinize, since a public listing exposes the gap between revenue growth and the capital intensity behind it. The open question is whether cheaper inference eventually widens adoption enough to close the cost gap, or whether pricing pressure keeps compressing margins regardless of volume.